Abstract
In this review, I summarize data in the biological literature which underscore the utility of a genetic approach to protein structure/function problems, with emphasis on binding phenomena, particularly of cytokine and growth factor/receptor interactions. Useful parallels or contrasts to chemical ligand/receptor systems and DNA binding protein interactions are examined where they simplify the analysis of protein ligand/receptor interactions. This approach was prompted by the fact that purely rational approaches, based on resolution of the three dimensional structure of proteins, are limited because such data is available for fewer than 3% of the 17,000 proteins for which the amino acid sequence has been deduced by molecular biology techniques.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Zurawski, S.M., lmler, J.-L and Zurawski, G. 1990. Partial agonist/antagonist mouse interleukin 2 proteins indicate that a 3rd component of the receptor complex functions in signal transduction. EMBO J. 9: 3899–3955.
Labriola-Tomkins, E., Chandron, C., Kaffka, K.L., Biondi, D., Graves, B.J., Hatada, M., Madison, V.S., Karas, J., Killian, P.L. and Ju, G. 1991. Identification of the discontinuous binding site in human interleukin 1 beta for type 1 interleukin 1 receptor. Proc. Nat. Acad. Sci. USA 8: 11182–11186.
Ju, G., Labriola-Tompkins, E., Campen, C., Benjamin, W.R., Karas, J., Plocinski, J., Biondi, D., Killian, P.L., Eisenberg, S.P. and Evans, J. 1991. Conversion of the IL1 receptor antagonist into an agonist by site specific mutagenesis. Proc. Nat. Acad. Sci. USA 88: 2652–2662.
Matzuk, M., Keene, J.L. and Boime, I. 1989. Site specificity of the chorionic gonadotropin N-linked oligosaccharides in signal transduction. J. Biol. Chem. 264: 2409–2414.
Douglas, W.W. 1985. Polypeptides—Angiotensin, plasma kinins, and others, p. 647. In: The Pharmacological Basis of Experimental Therapeutics, 7th ed. Goodman, L.S., Gilman, A.G., Rall, T. and Murad, F. (Eds.). Macmillan Publishing Co., NY.
Roussel, M.F., Downing, J.R. and Sherr, C.J. 1990. Transforming activities of human CSF receptors with different point mutations at codon 301 in the extracellular domain. Ontogene 5: 25–30.
Yoshimura, A., Longmore, G. and Lodish, H.F. 1990. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone independent activation and tumorigenicity. Nature 348: 647–649.
Bargmann, C.I., Hung, M.-C. and Weinberg, R.A. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45: 649–657.
Kjelsberg, M.A., Coteccia, S., Ostrowski, J., Caron, M.G. and Lefkowitz, R.J. 1992. Constitutive activation of the α1B adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J. Biol. Chem. 267: 1430–1433.
Revah, F., Bertrand, D., Galzi, J.L., Devillers-Thiery, A., Mulle, C., Hussy, N., Bertrand, S., Ballivet, M. and Changeux, J.P. 1991. Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature 353: 846–849.
Kleina, L. and Miller, J. 1990. Genetic studies of the lac represser XIII: Extensive amino acid replacement generated by the use of natural and synthetic nonsense suppressors. J. Mol. Biol. 212: 295–318.
Kelly, R.J. and Yanofsky, C. 1985. Mutational studies within the trp repressor of Escherichia coli support the helix-turn-helix model of repressor recognition of operator DNA. Proc. Nat. Acad. Sci. 82: 483–487.
Benhamon, B., Garcia, T., Lerouge, T., Vergezac, A., Gufflo, D., Bigogne, C., Chambon, P. and Gronenmeyer, H. 1992. A single amino acid determines the sensitivity of the progesterone receptor to RU486. Science 255: 206–209.
Hall, B.G. and Zuzel, T. 1980. Evolution of a new enzymatic function by recombination within a gene. Proc. Nat. Acad. Sci. USA 77: 3529–3533.
Hall, B.G., Betts, P.W. and Wooton, J.C. 1989. DNA sequence analysis of artificially evolved ebg enzyme and ebg repressor genes. Genetics 123: 635–648.
Lau, F. and Fersht, A. 1987. Conversion of allosteric inhibition to activation in phosphofructokinase by protein engineering. Nature 326: 811–812.
Patthy, L. 1985. Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules. Cell 41: 657–663.
Baron, M., Norman, D.G. and Campbell, I.G. 1991. Protein modules. Trends in Bio. Sci. 16: 13–17.
Eisenberg, S.P., Brewer, M.T., Verderber, E., Heimdal, P., Brandhuber, B.J. and Thompson, R.C. 1991. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc. Nat. Acad. Sci. USA 88: 5232–5236.
Gehrke, L., Jobling, S.A., Park, L.S., McDonald, B., Rossenwasser, L.J. and Auron, P.E. 1990. A point mutation uncouples human interleukin 1β biological activity and receptor binding. J. Biol. Ghem. 265: 5922–5925.
Fane, B. and King, J. 1991. Intragenic suppressors of folding defects in the P22 tailspike protein. Genetics 127: 263–277.
Hinrichsen, R., Pollock, M., Hennessey, T. and Russell, C. 1991. An intra-genie suppressor of a calmodulin mutation in paramecium: genetic and biochemical characterization. Genetics 129: 717–725.
Brandhuber, B.J., Boone, T., Kenney, W.C. and McKay, D.B. 1987. Three dimensional structure of IL2. Science 238: 1707–1709.
Ultsch, M., deVos, A.M. and KossikofT, A.A. 1991. Crystals of the complex between human growth hormone and the extracellular domain of the receptor. J. Mol. Biol. 222: 865–868.
Jaffe, J.H. and Martin, W.R. 1985. Opioid analgesics and antagonists, p. 494. In: The Pharmacological Basis of Experimental Therapeutics, 7th ed. op. cit
Snider, R., Constantine, J., Lowe, J. III, Longo, K., Lebel, W., Woody, H., Drozda, S., Desai, M., Vinick, E., Spencer, R. and Hess, H. 1991. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 251: 435–437.
Green, F.R., Lynch, B., and Kaiser, E.T. 1987. Biological and physical properties of a model calcitonin containing a glutamate residue interupting the hydrophobic face of the idealized amphiphilic α-helical region. Proc. Nat. Acad. Sci. USA 84: 8340–8344.
Dripps, D., Brandhuber, B.J., Thompson, R.C., and Eisenberg, S. 1991. Interleukin 1 (1L1) receptor antagonist binds to the 80KDa IL1 receptor but does not initiate 1L1 signal transduction. J. Biol. Chem. 266: 10331–10336.
Cohen, J.B. 1978. Ligand binding properties of membrane bound cholinergic receptors of Torpedo marmorata, p. 99–128. In: Molecular Specialization and Symmetry in Membrane Function. Soloman, A.K. and Karnovsky, M. (Eds.). Harvard Univ. Press, Cambridge, MA.
Neubig, R.R. and Cohen, J.B. 1979. Equilibrium binding of [3H] tubo-curarine and [3H]-acetylcholine by Torpedo postsynaptic membranes: stoichiometry and ligand interactions. Biochemistry 18: 5464–5475.
Smee, D.F., Boehme, R., Chernow, M., Binko, B.P. and Matthews, T.R. 1985. Intracellular metabolism and enzymatic phosphorylation of 9- (1,3 dihydroxy-2-propoxymethyl) guanine and acyclovir in herpes simplex virus infected and uninfected cells. Biochemical Pharmacology 34: 1049–1056.
Ling, Z.D., Gillis, S., Hart, L.J. and Matheson, D.D. 1991. Particle concentration fluorescence immunoassay for measuring IL6 receptor numbers. Cytokine 3: 17–20.
King, K., Dohlman, H.G., Thorner, J., Caron, M.G. and Lefkowitz, R.J. 1990. Control of yeast mating signal transduction by a β2 adrenergic receptor and Gsα subunit. Science 250: 121–123.
Arkin, A.P. and Youvan, D.C. 1992. Optimizing nucleotide mixtures to encode specific subsets of amino acids for semi-random mutagenesis. Bio/Technology 10: 297–300.
Kunkel, T., Roberts, J. and Zakour, R.A. 1987. Rapid and efficient site specific mutagenesis without phenotypic selection. Meth. Enz. 154: 367–382.
Sayers, J.R., Schmidt, W. and Eckstein, F. 1988. 5′–3′ exonuclease in phosphothioale-based oligonucleotide directed mutagenesis. Nucl. Acids Res. 16: 791–802.
Vandeyar, M., Weiner, M., Hutton, C. and Batt, C. 1988. A simple and rapid method for the selection of oligonucleotide directed mutants. Gene 65: 129–133.
Normanly, J., Masson, J.-M., Kleina, L.G., Abelson, J. and Miller, J.H. 1986. Construction of two Escherichia coli amber suppressor genes: tRNAPhe and tRNACys . Proc. Nat. Acad. Sci. USA 83: 6548–6552.
Kleina, L., Masson, J., Normanly, J., Abelson, J. and Miller, J.H. 1990. Construction of E. coli amber suppressor tRNA genes. II. Synthesis of additional tRNA genes and improvement of suppressor efficiency. J. Mol. Biol. 213: 705–717.
Normanly, J., Kleina, L., Masson, J., Abelson, J. and Miller, J.H. 1990. Construction of amber suppressor tRNA genes. III. Determination of tRNA specificity. J. Mol. Biol. 213: 719–726.
Medynski, D. and Coffino, P. 1989. Rapid generation and identification of multiple mutants of ornithine decarboxylase utilizing a colony color screen and tRNA amber nonsense suppressors. Amer. Soc. of Microbiol. Biotechnology Conf. 2: 12.
Ellman, J.A., Mandel, D. and Schultz, P.G. 1992. Site specific incorporation of novel backbone structures into proteins. Science 255: 197–200.
Bass, S., Greene, R. and Wells, J. 1990. Hormone phage: An enrichment method for variant proteins with altered binding properties. Proteins 8: 309–314.
Nagai, K. and Thogerson, H.C. 1984. Generation of β globulin by sequence-specific proteolysis of a hybrid protein produced in E. coli. Nature 309: 810–812.
Cwirla, P., Barrett, W. and Dower, W.J. 1990. Peptides on phage: A vast library of peptides identifying ligands. Proc. Nat. Acad. Sci. USA 87: 6378–6382.
McCafferty, J., Griffiths, R.D., Winter, G. and Chiswell, D.J. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348: 552–554.
Yamasaki, K., Taga T., Hirata, Y., Yawata, H., Kawasaki, Y., Seed, B., Taniguchi, T., Hirano.T. and Kishimoto, T. 1988. Cloning and expression of the human interleukin 6 receptor. Science 241: 825–828.
Maliszewski, C.R., Sato, T.A., Van den Bos, T., Waugh, S., Dower, S.K., Slack, J., Beckman, M. and Grabstein, K. 1990. Cytokine receptors and B cell function: Recombinant soluble receptors specifically inhibit IL-1 and IL-4 induced B cell activities. J. Immunology 19: 3028–3033.
Goodwin, R.G., Friend, D., Ziegler, S.F., Jerzy, R., Falk, B.A., Gumpel, S., Cosman, D., Dower, S.K., March, C.J. and Namen, A.E. 1990. Cloning of the human and murine 1L7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 60: 941–951.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Medynski, D. Genetic Approaches to Protein Structure and Function: Point Mutations as Modifiers of Protein Function. Nat Biotechnol 10, 1002–1006 (1992). https://doi.org/10.1038/nbt0992-1002
Issue date:
DOI: https://doi.org/10.1038/nbt0992-1002


